secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001558370-23-001085
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fortress Biotech prices $13.9M registered direct equity offering; warrants tied to subsidiary stakes
--------------------------------------------------------------------------------

- Issued 16.6M shares at $0.835/share for gross proceeds of ~$13.9M.
- Directors and officers purchased ~$3.3M of shares at same price, a premium to last close.
- Concurrent private placement grants rights to acquire ~3.5% equity in up to 20 new subsidiaries contingent on future deals.
- Contingent subsidiary securities exercisable for 10 years at FMV of subsidiary shares at time of trigger.
- Offering expected to close Feb 10, 2023; proceeds for working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000155837023001085/0001558370-23-001085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000155837023001085/fbio-20230207x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-001085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer